Movatterモバイル変換


[0]ホーム

URL:


AU2016219622A1 - Heterodimeric antibody FC-containing proteins and methods for production thereof - Google Patents

Heterodimeric antibody FC-containing proteins and methods for production thereof

Info

Publication number
AU2016219622A1
AU2016219622A1AU2016219622AAU2016219622AAU2016219622A1AU 2016219622 A1AU2016219622 A1AU 2016219622A1AU 2016219622 AAU2016219622 AAU 2016219622AAU 2016219622 AAU2016219622 AAU 2016219622AAU 2016219622 A1AU2016219622 A1AU 2016219622A1
Authority
AU
Australia
Prior art keywords
methods
production
containing proteins
heterodimeric antibody
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016219622A
Inventor
Patrick Van Berkel
Ewald Van Den Bremer
Bart De Goeij
Aran Frank Labrijn
Joyce Meesters
Joost J. Neijssen
Paul Parren
Janine Schuurman
Jan Van De Winkel
Tom Vink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genmab AS
Original Assignee
Genmab AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013203221Aexternal-prioritypatent/AU2013203221B2/en
Application filed by Genmab ASfiledCriticalGenmab AS
Priority to AU2016219622ApriorityCriticalpatent/AU2016219622A1/en
Publication of AU2016219622A1publicationCriticalpatent/AU2016219622A1/en
Priority to AU2018201503Aprioritypatent/AU2018201503A1/en
Priority to AU2019283898Aprioritypatent/AU2019283898C1/en
Priority to AU2022201608Aprioritypatent/AU2022201608B2/en
Abandonedlegal-statusCriticalCurrent

Links

Landscapes

Abstract

Novel heterodimeric antibody-Fc-containing proteins, such as bispecific antibodies, and novel methods for producing such proteins.
AU2016219622A2010-04-202016-08-24Heterodimeric antibody FC-containing proteins and methods for production thereofAbandonedAU2016219622A1 (en)

Priority Applications (4)

Application NumberPriority DateFiling DateTitle
AU2016219622AAU2016219622A1 (en)2010-04-202016-08-24Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2018201503AAU2018201503A1 (en)2010-04-202018-03-01Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2019283898AAU2019283898C1 (en)2010-04-202019-12-18Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2022201608AAU2022201608B2 (en)2010-04-202022-03-08Heterodimeric antibody FC-containing proteins and methods for production thereof

Applications Claiming Priority (5)

Application NumberPriority DateFiling DateTitle
DKPA2010003302010-04-20
US61/326,0822010-04-20
DKPA2010010662010-11-24
AU2013203221AAU2013203221B2 (en)2010-04-202013-04-09Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2016219622AAU2016219622A1 (en)2010-04-202016-08-24Heterodimeric antibody FC-containing proteins and methods for production thereof

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
AU2013203221ADivisionAU2013203221B2 (en)2010-04-202013-04-09Heterodimeric antibody FC-containing proteins and methods for production thereof

Related Child Applications (1)

Application NumberTitlePriority DateFiling Date
AU2018201503ADivisionAU2018201503A1 (en)2010-04-202018-03-01Heterodimeric antibody FC-containing proteins and methods for production thereof

Publications (1)

Publication NumberPublication Date
AU2016219622A1true AU2016219622A1 (en)2016-09-15

Family

ID=56898950

Family Applications (3)

Application NumberTitlePriority DateFiling Date
AU2016219622AAbandonedAU2016219622A1 (en)2010-04-202016-08-24Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2018201503AAbandonedAU2018201503A1 (en)2010-04-202018-03-01Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2019283898AActiveAU2019283898C1 (en)2010-04-202019-12-18Heterodimeric antibody FC-containing proteins and methods for production thereof

Family Applications After (2)

Application NumberTitlePriority DateFiling Date
AU2018201503AAbandonedAU2018201503A1 (en)2010-04-202018-03-01Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2019283898AActiveAU2019283898C1 (en)2010-04-202019-12-18Heterodimeric antibody FC-containing proteins and methods for production thereof

Country Status (1)

CountryLink
AU (3)AU2016219622A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
TWI544076B (en)*2005-03-312016-08-01Chugai Pharmaceutical Co Ltd A method of manufacturing a polypeptide that controls assembly
PL2235064T3 (en)*2008-01-072016-06-30Amgen IncMethod for making antibody fc-heterodimeric molecules using electrostatic steering effects

Also Published As

Publication numberPublication date
AU2019283898A1 (en)2020-01-23
AU2019283898B2 (en)2021-12-09
AU2018201503A1 (en)2018-03-22
AU2019283898C1 (en)2022-06-16

Similar Documents

PublicationPublication DateTitle
EP4477668A3 (en)Heterodimeric antibody fc-containing proteins and methods for production thereof
WO2010145792A8 (en)Bispecific antigen binding proteins
MX336682B (en)Antibodies against human csf-1r and uses thereof.
MX356337B (en)Antibodies against human csf-1r and uses thereof.
SG178886A1 (en)Humanized anti-cdcp1 antibodies
TW201129381A (en)Antibodies against human CSF-1R and uses thereof
SG10201805291TA (en)Production of heterodimeric proteins
AU2014247175A8 (en)Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5 and methods of use
NZ630568A (en)Methods and means for the production of ch3 domain-comprising molecules
MX2019003427A (en)Cell culture compositions and methods for polypeptide production.
MY170720A (en)Antibody formulations
MX359384B (en)Improved assembly of bispecific antibodies.
WO2013188693A8 (en)Antigen binding constructs to cd3
EA201171148A1 (en) ANTI-TELE-ANTAGONIST, SPECIFIC FOR THE ALPHA-4-BETA-7 HETERODIMER
MX342034B (en)Monovalent antigen binding proteins.
WO2009114702A3 (en)Recombinant production of authentic human proteins using human cell expression systems
WO2012064836A9 (en)Methods and compositions for neural disease immunotherapy
EP4375371A3 (en)Methods for the manufacture of proteolytically processed polypeptides
WO2012068317A3 (en)Methods for producing recombinant proteins
MX2015011781A (en)Cell culture media and methods of antibody production.
WO2010121093A3 (en)Humanized antibody compositions and methods for binding lysophosphatidic acid
NZ629553A (en)Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
EP4458858A3 (en)Method for the production of immunoglobulin single variable domains
WO2010079510A3 (en)Anti-rhd monoclonal antibodies
MX2016001678A (en)Expression constructs and methods for expressing polypeptides in eukaryotic cells.

Legal Events

DateCodeTitleDescription
MK5Application lapsed section 142(2)(e) - patent request and compl. specification not accepted

[8]ページ先頭

©2009-2025 Movatter.jp